Research Article
Prognostic Value of Concurrent Expression of C-MYC and BCL2 in Intravascular Large B-Cell Lymphoma: A 10-Year Retrospective Study
Table 3
Immunochemical findings and cell-of-origin classification.
| Patient number | CD3 | CD20 | CD10 | BCL6 | MUM-1 | Cell-of-origin classification | CD5 | CD30 | BCL2 | C-MYC | P53 |
| 1 | - | + | - | + | - | GCB-like | - | - | + | - | + | 2 | - | + | NA | NA | NA | NA | NA | NA | NA | NA | NA | 3 | - | + | - | - | + | Non-GCB-like | - | - | + | + | + | 4 | - | + | - | + | + | Non-GCB-like | - | - | + | - | + | 5 | - | + | - | + | + | Non-GCB-like | - | - | + | - | + | 6 | - | + | NA | NA | NA | NA | NA | NA | NA | NA | NA | 7 | - | + | - | + | - | GCB-like | - | - | + | - | - | 8 | - | + | - | - | - | Unclassifiable | - | - | - | - | - | 9 | - | + | - | - | - | Unclassifiable | - | - | - | - | - | 10 | - | + | - | + | + | Non-GCB-like | - | - | + | + | + | 11 | - | + | - | + | + | Non-GCB-like | + | - | + | + | + | 12 | - | + | - | + | + | Non-GCB-like | - | - | + | + | + | 13 | - | + | - | + | + | Non-GCB-like | - | - | + | + | + | 14 | - | + | - | - | + | Non-GCB-like | - | - | + | - | - | 15 | - | + | - | + | + | Non-GCB-like | - | - | + | + | + | 16 | - | + | - | - | + | Non-GCB-like | - | - | + | - | + | 17 | - | + | - | + | + | Non-GCB-like | + | + | + | - | + | Positive (%) | 0 | 100.0 | 0 | 66.7 | 73.3 | - | 13.3 | 6.7 | 86.7 | 40.0 | 73.3 |
|
|
GCB: germinal center B-cell; Non-GCB = nongerminal center B-cell; NA: no data available.
|